Effect of ciclesonide treatment on allergen-induced changes in T cell regulation in asthma

International Archives of Allergy and Immunology

Volumn 145, Issue 2, 2008, Pages 111-121

  Heijink, Irene H ^a   Kauffman, Henk F ^a   Vellenga, Edo ^a   Veltman Starkenburg, Christa A ^a   Postma, Dirkje S ^a   De Monchy, Jan G R ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Adrenergic receptor; Asthma allergic; Chemokine; Corticosteroid; Th2 cells

Indexed keywords

ALLERGEN; BETA 2 ADRENERGIC RECEPTOR; CD28 ANTIGEN; CD3 ANTIGEN; CICLESONIDE; FENOTEROL; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; PLACEBO; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; LYMPHOCYTE MIGRATION; MALE; MULTICENTER STUDY; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPUTUM ANALYSIS; T LYMPHOCYTE; TH2 CELL; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ALLERGENS; ANTI-ASTHMATIC AGENTS; ARRESTINS; ASTHMA; CELL MOVEMENT; CHEMOKINE CCL17; CHEMOKINE CCL4; CYTOKINES; DOUBLE-BLIND METHOD; FEMALE; FENOTEROL; HUMANS; MALE; MIDDLE AGED; PREGNENEDIONES; RECEPTORS, ADRENERGIC, BETA-2; SPUTUM; T-LYMPHOCYTE SUBSETS; TH2 CELLS;

EID: 38349163137     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000108136     Document Type: Article

References (46)

1. Ying S, Durham SR, Corrigan CJ, Hamid Q, Kay AB: Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon-γ) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects. Am J Respir Cell Mol Biol 1995;12:477-487.
2. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, et al: Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
3. Bentley AM, Meng Q, Robinson DS, Hamid Q, Kay AB, Durham SR: Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am J Respir Cell Mol Biol 1993;8:35-42.
4. Borgonovo B, Casorati G, Frittoli E, Gaffi D, Crimi E, Burastero SE: Recruitment of circulating allergen-specific T lymphocytes to the lung on allergen challenge in asthma. J Allergy Clin Immunol 1997;100:669-678.
5. Gerblich AA, Salik H, Schuyler MR: Dynamic T-cell changes in peripheral blood and bronchoalveolar lavage after antigen bronchoprovocation in asthmatics. Am Rev Respir Dis 1991;143:533-537.
6. Lara-Marquez ML, Deykin A, Krinzman S, Listman J, Israel E, He H, et al: Analysis of T-cell activation after bronchial allergen challenge in patients with atopic asthma. J Allergy Clin Immunol 1998;101:699-708.
7. Robinson D, Hamid Q, Bentley A, Ying S, Kay AB, Durham SR: Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol 1993;92:313-324.
8. Till S, Durham S, Dickason R, Huston D, Bungre J, Walker S, et al: IL-13 production by allergen-stimulated T cells is increased in allergic disease and associated with IL-5 but not IFN-γ expression. Immunology 1997;91:53-57.
9. Till SJ, Durham SR, Rajakulasingam K, Humbert M, Huston D, Dickason R, et al: Allergen-induced proliferation and interleukin-5 production by bronchoalveolar lavage and blood T cells after segmental allergen challenge. Am J Respir Crit Care Med 1998;158:404-411.
10. Tang C, Rolland JM, Ward C, Quan B, Walters EH: Allergen-induced airway reactions in atopic asthmatics correlate with allergen-specific IL-5 response by BAL cells. Respirology 1997;2:45-55.
11. Panina-Bordignon P, Papi A, Mariani M, Di Lucia P, Casoni G, Bellettato C, et al: The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics. J Clin Invest 2001;107:1357-1364.
12. Nouri-Aria KT, Wilson D, Francis JN, Jopling LA, Jacobson MR, Hodge MR, et al: CCR4 in human allergen-induced late responses in the skin and lung. Eur J Immunol 2002;32:1933-1938.
13. Kim CH, Rott L, Kunkel EJ, Genovese MC, Andrew DP, Wu L, et al: Rules of chemokine receptor association with T cell polarization in vivo. J Clin Invest 2001;108:1331-1339.
14. Kallinich T, Schmidt S, Hamelmann E, Fischer A, Qin S, Luttmann W, et al: Chemokine-receptor expression on T cells in lung compartments of challenged asthmatic patients. Clin Exp Allergy 2005;35:26-33.
15. Morgan AJ, Symon FA, Berry MA, Pavord ID, Corrigan CJ, Wardlaw AJ: IL-4-expressing bronchoalveolar T cells from asthmatic and healthy subjects preferentially express CCR 3 and CCR 4. J Allergy Clin Immunol 2005;116:594-600.
16. Campbell JJ, Brightling CE, Symon FA, Qin S, Murphy KE, Hodge M, et al: Expression of chemokine receptors by lung T cells from normal and asthmatic subjects. J Immunol 2001;166:2842-2848.
17. Berin MC, Eckmann L, Broide DH, Kagnoff MF: Regulated production of the T helper 2-type T-cell chemoattractant TARC by human bronchial epithelial cells in vitro and in human lung xenografts. Am J Respir Cell Mol Biol 2001;24:382-389.
18. Leung TF, Wong CK, Lam CW, Li AM, Ip WK, Wong GW, et al: Plasma TARC concentration may be a useful marker for asthmatic exacerbation in children. Eur Respir J 2003;21:616-620.
19. Bochner BS, Hudson SA, Xiao HQ, Liu MC: Release of both CCR4-active and CXCR3-active chemokines during human allergic pulmonary late-phase reactions. J Allergy Clin Immunol 2003;112:930-934.
20. Sekiya T, Yamada H, Yamaguchi M, Yamamoto K, Ishii A, Yoshie O, et al: Increased levels of a TH2-type CC chemokine thymus and activation-regulated chemokine (TARC) in serum and induced sputum of asthmatics. Allergy 2002;57:173-177.
21. Diego PG, Paola PB, Giorgio PL, Alessandro B, Michela R, Margherita M, et al: CC chemokine receptor expression in childhood asthma is influenced by natural allergen exposure. Pediatr Allergy Immunol 2006;17:495-500.
22. 2-adrenergic regulation of T cell activity after allergen challenge in asthma. Clin Exp Allergy 2004;34:1356-1363.
23. Barnes PJ: β-Adrenergic receptors and their regulation. Am J Respir Crit Care Med 1995;152:838-860.
24. Gilman AG: G proteins: transducers of receptor-generated signals. Annu Rev Biochem 1987;56:615-649.
25. Meurs H, Koeter GH, de Vries K, Kauffman HF: The β-adrenergic system and allergic bronchial asthma: changes in lymphocyte β-adrenergic receptor number and adenylate cyclase activity after an allergen-induced asthmatic attack. J Allergy Clin Immunol 1982;70:272-280.
26. Meurs H, Kauffman HF, Timmermans A, de Monchy JG, Koeter GH, de Vries K: Specific immunological modulation of lymphocyte adenylate cyclase in asthmatic patients after allergenic bronchial provocation. Int Arch Allergy Appl Immunol 1986;81:224-229.
27. 2-adrenergic receptor signaling in human peripheral blood T lymphocytes. Am J Physiol Lung Cell Mol Physiol 2005;289:L53-L59.
28. Reynolds NA, Scott LJ: Ciclesonide. Drugs 2004;64:511-519.
29. Christie P: Ciclesonide: a novel inhaled corticosteroid for asthma. Drugs Today (Barc) 2004;40:569-576.
30. Pease JE: Asthma, allergy and chemokines. Curr Drug Targets 2006;7:3-12.
31. Romagnani S: Cytokines and chemoattractants in allergic inflammation. Mol Immunol 2002;38:881-885.
32. Rose CE Jr, Sung SS, Fu SM: Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung. Microcirculation 2003;10:273-288.
33. Schuh JM, Blease K, Hogaboam CM: CXCR2 is necessary for the development and persistence of chronic fungal asthma in mice. J Immunol 2002;168:1447-1456.
34. O'Byrne PM, Dolovich J, Hargreave FE: Late asthmatic responses. Am Rev Respir Dis 1987;136:740-751.
35. Pizzichini E, Pizzichini MM, Efthimiadis A, Evans S, Morris MM, Squillace D, et al: Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996;154:308-317.
36. Borger P, Kauffman HF, Postma DS, Vellenga E: Interleukin-4 gene expression in activated human T lymphocytes is regulated by the cyclic adenosine monophosphate-dependent signaling pathway. Blood 1996;87:691-698.
37. Borger P, Ten Hacken NH, Vellenga E, Kauffman HF, Postma DS: Peripheral blood T lymphocytes from asthmatic patients are primed for enhanced expression of interleukin (IL)-4 and IL-5 mRNA: associations with lung function and serum IgE. Clin Exp Allergy 1999;29:772-779.
38. Heijink IH, Vellenga E, Borger P, Postma DS, Monchy JG, Kauffman HF: Polarized Th1 and Th2 cells are less responsive to negative feedback by receptors coupled to the AC/cAMP system compared to freshly isolated T cells. Br J Pharmacol 2003;138:1441-1450.
39. Hoekstra MO, Hoekstra Y, De Reus D, Rutgers B, Gerritsen J, Kauffman HF: Interleukin-4, interferon-γ and interleukin-5 in peripheral blood of children with moderate atopic asthma. Clin Exp Allergy 1997;27:1254-1260.
40. Hawes BE, Luttrell LM, van Biesen T, Lefkowitz RJ: Phosphatidylinositol 3-kinase is an early intermediate in the G beta gamma-mediated mitogen-activated protein kinase signaling pathway. J Biol Chem 1996;271:12133-12136.
41. Kawayama T, O'Byrne PM, Watson RM, Killian KJ, Duong M, Yoshida M, et al: Effects of inhaled ciclesonide on circulating Thelper type 1/T-helper type 2 cells in atopic asthmatics after allergen challenge. Clin Exp Allergy 2006;36:1417-1424.
42. Gauvreau GM, Boulet LP, Postma DS, Kawayama T, Watson RM, Duong M, et al: Effect of low-dose ciclesonide on allergen-induced responses in subjects with mild allergic asthma. J Allergy Clin Immunol 2005;116:285-291.
43. Nave R, Bethke TD, van Marle SP, Zech K: Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects. Clin Pharmacokinet 2004;43:479-486.
44. Laitinen LA, Laitinen A, Heino M, Haahtela T: Eosinophilic airway inflammation during exacerbation of asthma and its treatment with inhaled corticosteroid. Am Rev Respir Dis 1991;143:423-427.
45. 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol 1992;90:32-42.
46. Chung KF: The complementary role of glucocorticosteroids and long-acting β-adrenergic agonists. Allergy 1998;53(suppl 42):7-13.